MeSH tree: C06.689.750
The U.K. is asking patients whose pancreas became dangerously inflamed after taking obesity drugs like Wegovy and Zepbound to come in for tests to understand whether there's a genetic risk for the condition.
Jun 26, 2025
0
23
Academics at King's College London and the University of East Anglia have released guidance for GPs on how to manage patients who may be privately accessing weight loss drugs.
Jun 25, 2025
0
19
Acute pancreatitis is among the most common gastrointestinal conditions requiring inpatient hospital care in the United States.
Jun 18, 2025
0
15
Triglycerides are a vital source of energy, but when levels become dangerously high, they can lead to serious health complications, including pancreatitis. One such condition, chylomicronemia, is a rare but severe disorder ...
Mar 28, 2025
0
16
Familial chilomicronemia syndrome (FCS) is a genetic disease that causes persistent accumulation of triglycerides in the blood—more than 10 times higher than normal. The main symptoms are severe abdominal pain and frequent ...
Feb 26, 2025
0
13
GLP-1 medications initially were used to help people with diabetes improve their insulin resistance and hunger cravings. However, over the past few years, these medications have become popular due to their weight loss and ...
Feb 17, 2025
0
28
Several years ago, a little-known drug named Ozempic—previously used only to treat diabetes—emerged as a promising new drug for weight management.
Jan 25, 2025
0
34
Demand for weight-loss medications sold under brand names such as Ozempic and Wegovy continues to surge, with a study reporting one in eight Americans has taken or is currently using the drugs to treat diabetes, heart disease ...
Jan 20, 2025
0
43
Tryngolza (olezarsen) has been approved by the U.S. Food and Drug Administration as an adjunct to diet to reduce triglycerides in adults with familial chylomicronemia syndrome (FCS), which can lead to potentially life-threatening ...
Dec 29, 2024
0
26
The U.S. Food and Drug Administration has approved the first generic referencing Victoza (liraglutide; Hikma Pharmaceuticals), a glucagon-like peptide-1 (GLP-1) receptor agonist indicated to improve glycemic control in adults ...
Dec 27, 2024
0
37
